Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.

N. Baber, D. W. Evans, G. Howitt, Timothy G. Wilson, John A. Lewis, P. M. Dawes, Keith Handler, Richard Tuson

Heart · 1980 · 166 citations · 25 references

DOIFull text

Open access

Concepts

Abstract

A multicentre study of survivors of an anterior myocardial infarction is reported. The trial consisted of 720 patients and was a double-blind, placebo-controlled study with propranolol 40 mg three times a day. Trial entry was at two to 14 days (mean 8.5 days) and follow-up at one, three, and in most centres, six and nine months. The trial was designed to detect a 50 per cent reduction in mortality and this was not shown. The non-fatal reinfarction rate was similar in both groups. Subgroup analysis identified several prognostic risk factors for death, none of which interacted with treatment.

References

25